Literature DB >> 16451393

Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*.

Alessia Pepe1, Massimo Lombardi, Vincenzo Positano, Eliana Cracolici, Marcello Capra, Roberto Malizia, Luciano Prossomariti, Daniele De Marchi, Massimo Midiri, Aurelio Maggio.   

Abstract

OBJECTIVES: Oral deferiprone (L1) appears to be promising in the treatment of beta-thalassemia major (TM) patients. T2* magnetic resonance imaging (MRI) with a single measurement in the mid-ventricular septum was validated as a quantitative evaluation of myocardial iron overload. Previous studies suggested a marked heterogeneity of iron distribution in the myocardium. We set up a multislice multiecho T2* MRI for the detection of this heterogeneity. The aim of our study was to investigate differences between the L1 vs. the subcutaneous desferrioxamine (DF)-treated patients using this new approach.
METHODS: Thirty-six beta-TM patients (age 29 +/- 8 yr) underwent MRI. Eighteen patients received long-term L1, and 18 other patients matched for age and sex received DF. T2* multiecho sequences on three short axis views of the left ventricle were obtained and analyzed by custom-made software. In each slice, the myocardium was automatically segmented into four segments. Cine-dynamic images were also obtained to evaluate biventricular function.
RESULTS: For multislice T2* technique, the coefficient of variation for intra- and inter-observer, and inter-study reproducibility was 3.9%, 4.7%, and 5.5%, respectively. The global heart T2* value was significantly higher in the L1 vs. DF group (35 +/- 7 vs. 27 +/- 2 ms; P = 0.02). The number of segments with normal T2* value (>20 ms) was significantly higher in the L1 vs. the DF group (11 +/- 1 vs. 8 +/- 5 segments; P = 0.03). We did not detect significant differences in biventricular function parameters.
CONCLUSIONS: This new approach confirms that L1 could be more effective than DF in removal of myocardial iron.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451393     DOI: 10.1111/j.1600-0609.2005.00587.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  30 in total

1.  Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Authors:  B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

2.  Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.

Authors:  Benedikt Schaefer; David Haschka; Armin Finkenstedt; Britt-Sabina Petersen; Igor Theurl; Benjamin Henninger; Andreas R Janecke; Chia-Yu Wang; Herbert Y Lin; Lothar Veits; Wolfgang Vogel; Günter Weiss; Andre Franke; Heinz Zoller
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

3.  Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Authors:  Vineeta Ojha; Kartik P Ganga; Tulika Seth; Ambuj Roy; Nitish Naik; Priya Jagia; Gurpreet S Gulati; Sanjeev Kumar; Sanjiv Sharma
Journal:  Eur Radiol       Date:  2021-03-15       Impact factor: 5.315

4.  Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi-Kong Li; Vip Viprakasit; Mohsen S Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

5.  Cardiac T2* and lipid measurement at 3.0 T-initial experience.

Authors:  Declan P O'Regan; Martina F Callaghan; Julie Fitzpatrick; Rossi P Naoumova; Joseph V Hajnal; Stephan A Schmitz
Journal:  Eur Radiol       Date:  2007-11-23       Impact factor: 5.315

Review 6.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 7.  Evaluation of myocardial iron overload using magnetic resonance imaging.

Authors:  Sophie Mavrogeni
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

8.  Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Gillian C Smith; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

9.  Fast approximation to pixelwise relaxivity maps: validation in iron overloaded subjects.

Authors:  Antonella Meloni; Heather Zmyewski; Hugh Young Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Magn Reson Imaging       Date:  2013-06-15       Impact factor: 2.546

10.  Early detection of iron overload in the heart: a key role for MRI!

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-24       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.